Insight Molecular Diagnostics Inc. (OCX)
NASDAQ
Closed
Oct 8, 2026
Day's Range
3.1352 wk Range
2.42Overview - OCX - Insight Molecular Diagnostics Inc.
Key Statistics
Valuation
Enterprise Value
52.27M
P/E (Trailing)
‪-0.70‬
P/E (Forward)
‪-1.84‬
PEG Ratio
‪0.04‬
Price / Sales (TTM)
‪30.43‬
Price / Book
‪95.66‬
EV / EBITDA
‪-2.46‬
Profitability
Gross Margin
‪67.56%‬
Profit Margin
‪39.34%‬
Operating Margin
‪-3,220.57%‬
Return on Assets
‪-173.67%‬
Return on Equity
‪496.38%‬
Ownership
Shares Outstanding
28.59M
Analyst Consensus
4 analysts
Market Cap - OCX - Insight Molecular Diagnostics Inc.
Peers - OCX - Insight Molecular Diagnostics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
Profile Summary - OCX - Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
